{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T07:16:15Z","timestamp":1793344575852,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010790","name":"Erasmus Plus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006692","name":"Universit\u00e0 degli Studi di Torino","doi-asserted-by":"publisher","award":["PIPA_RILO_22_01"],"award-info":[{"award-number":["PIPA_RILO_22_01"]}],"id":[{"id":"10.13039\/501100006692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006692","name":"Universit\u00e0 degli Studi di Torino","doi-asserted-by":"publisher","award":["LOLM_RILO_23_01"],"award-info":[{"award-number":["LOLM_RILO_23_01"]}],"id":[{"id":"10.13039\/501100006692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006692","name":"Universit\u00e0 degli Studi di Torino","doi-asserted-by":"publisher","award":["BOSD_RILO_24_01"],"award-info":[{"award-number":["BOSD_RILO_24_01"]}],"id":[{"id":"10.13039\/501100006692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001671","name":"ESRF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-21-ESRE-0011"],"award-info":[{"award-number":["ANR-21-ESRE-0011"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014355","name":"Nirma University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014355","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejmech.2026.118753","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T07:56:20Z","timestamp":1772870180000},"page":"118753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Structure-based design of new pyrazole inhibitors targeting Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH)"],"prefix":"10.1016","volume":"309","author":[{"given":"Agnese C.","family":"Pippione","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Villella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Fornaseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Giorgis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manmohan","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Rolando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Sainas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrain","family":"Salamanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Gimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Cojean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek K.","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Buccinn\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Ramondetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Piccinini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziano","family":"Tuccinardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Miggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco L.","family":"Lolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4929-4460","authenticated-orcid":false,"given":"Donatella","family":"Boschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118753_bib1","series-title":"World Malaria Report 2025","year":"2025"},{"key":"10.1016\/j.ejmech.2026.118753_bib2","article-title":"Impact of the COVID-19 pandemic on malaria control in Africa: a preliminary analysis","volume":"8","author":"Gao","year":"2023","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.118753_bib3","doi-asserted-by":"crossref","first-page":"e591","DOI":"10.1016\/S1473-3099(24)00141-5","article-title":"The emergence of artemisinin partial resistance in Africa: how do we respond?","volume":"24","author":"Rosenthal","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.118753_bib4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41579-024-01008-2","article-title":"Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa","volume":"22","author":"Rosenthal","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2026.118753_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1308193","article-title":"Promising antimalarial hits from phenotypic screens: a review of recently-described multi-stage actives and their modes of action","volume":"13","author":"Luo","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejmech.2026.118753_bib6","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41579-024-01099-x","article-title":"Towards next-generation treatment options to combat Plasmodium falciparum malaria","volume":"23","author":"Okombo","year":"2025","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2026.118753_bib7","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cmi.2025.03.009","article-title":"The non-artemisinin antimalarial drugs under development: a review","volume":"31","author":"Okwu","year":"2025","journal-title":"Clin. Microbiol. Infection"},{"key":"10.1016\/j.ejmech.2026.118753_bib8","series-title":"Mmv's Strategy to 2030","year":"2026"},{"key":"10.1016\/j.ejmech.2026.118753_bib9","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41573-023-00772-9","article-title":"Antimalarial drug discovery: progress and approaches","volume":"22","author":"Siqueira-Neto","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118753_bib10","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1021\/acs.jmedchem.3c01828","article-title":"Emerging drug targets for antimalarial drug discovery: validation and insights into molecular mechanisms of function","volume":"67","author":"Cheuka","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118753_bib11","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.4155\/fmc-2017-0250","article-title":"Plasmodium falciparum dihydroorotate dehydrogenase: a drug target against malaria","volume":"10","author":"Hoelz","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118753_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111681","article-title":"Dihydroorotate dehydrogenase inhibitors in anti-infective drug research","volume":"183","author":"Boschi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118753_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107249","article-title":"A comprehensive review of synthetic strategies and SAR studies for the discovery of PfDHODH inhibitors as antimalarial agents. Part 1: triazolopyrimidine, isoxazolopyrimidine and pyrrole-based (DSM) compounds","volume":"146","author":"Sharma","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118753_bib26","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1021\/jm200592f","article-title":"Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential","volume":"54","author":"Coteron","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118753_bib18","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1021\/acs.jmedchem.1c00173","article-title":"Potent antimalarials with development potential identified by structure-guided computational optimization of a pyrrole-based dihydroorotate dehydrogenase inhibitor series","volume":"64","author":"Palmer","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118753_bib16","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1021\/acs.jmedchem.4c02394","article-title":"Structure-based discovery and development of highly potent dihydroorotate dehydrogenase inhibitors for malaria chemoprevention","volume":"68","author":"Nie","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118753_bib22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ejmech.2018.11.044","article-title":"Hydroxyazole scaffold-based Plasmodium falciparum dihydroorotate dehydrogenase inhibitors: synthesis, biological evaluation and X-ray structural studies","volume":"163","author":"Pippione","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118753_bib14","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S1473-3099(18)30309-8","article-title":"Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study","volume":"18","author":"Llanos-Cuentas","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.118753_bib15","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S1473-3099(17)30171-8","article-title":"Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a\/1b randomised study","volume":"17","author":"McCarthy","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.118753_bib17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s12936-024-05128-1","article-title":"Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile","volume":"23","author":"El Gaaloul","year":"2024","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2026.118753_bib19","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1021\/acs.jmedchem.0c00311","article-title":"Lead optimization of a pyrrole-based dihydroorotate dehydrogenase inhibitor series for the treatment of malaria","volume":"63","author":"Kokkonda","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118753_bib20","series-title":"MMVFree, an open-access Tool for Malaria Chemoprevention","year":"2026"},{"key":"10.1016\/j.ejmech.2026.118753_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107754","article-title":"A comprehensive review of synthetic strategies and SAR studies for the discovery of PfDHODH inhibitors as antimalarial agents. Part 2: non-DSM compounds","volume":"153","author":"Sharma","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118753_bib23","series-title":"Frontrunner Criteria and Templates for Antimalarial Drug Discovery","year":"2026"},{"key":"10.1016\/j.ejmech.2026.118753_bib24","doi-asserted-by":"crossref","first-page":"9461","DOI":"10.1021\/acs.jpcb.3c05738","article-title":"Deciphering interactions between potential inhibitors and the Plasmodium falciparum DHODH enzyme: a computational perspective","volume":"127","author":"Lima Costa","year":"2023","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejmech.2026.118753_bib25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1107\/S0907444905042642","article-title":"Structure of Plasmodium falciparum dihydroorotate dehydrogenase with a bound inhibitor","volume":"62","author":"Hurt","year":"2006","journal-title":"Acta. Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2026.118753_bib27","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1021\/cr500336u","article-title":"Preparation and utility of organic pentafluorosulfanyl-containing compounds","volume":"115","author":"Savoie","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2026.118753_bib28","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1021\/jm200265b","article-title":"Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice","volume":"54","author":"Gujjar","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118753_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2025.106099","article-title":"DHODH inhibitors: what will it take to get them into the clinic as antivirals?","volume":"236","author":"Luganini","year":"2025","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2026.118753_bib30","first-page":"16","article-title":"The medicinal chemist's guide to solving ADMET challenges","volume":"2","author":"Schnider","year":"2021","journal-title":"Roy. Soc. Chem."},{"key":"10.1016\/j.ejmech.2026.118753_bib31","doi-asserted-by":"crossref","first-page":"41827","DOI":"10.1074\/jbc.M206854200","article-title":"Malarial dihydroorotate dehydrogenase. Substrate and inhibitor specificity","volume":"277","author":"Baldwin","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118753_bib32","doi-asserted-by":"crossref","first-page":"12701","DOI":"10.1021\/acs.jmedchem.2c00496","article-title":"Targeting acute myelogenous leukemia using potent human dihydroorotate dehydrogenase inhibitors based on the 2-Hydroxypyrazolo[1,5- a]pyridine scaffold: SAR of the aryloxyaryl moiety","volume":"65","author":"Sainas","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118753_bib33","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1021\/ol802882k","article-title":"Selective monomethylation of anilines by Cu(OAc)2-Promoted cross-coupling with MeB(OH)2","volume":"11","author":"Gonz\u00e1lez","year":"2009","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2026.118753_bib34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejmech.2017.02.017","article-title":"Design, synthesis, biological evaluation and X-Ray structural studies of potent human dihydroorotate dehydrogenase inhibitors based on hydroxylated azole scaffolds","volume":"129","author":"Sainas","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118753_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1584\/jpestics.G09-50","article-title":"Synthesis and insecticidal activity of novel 1-alkyl-3-sulfonyloxypyrazole-4-carboxamide derivatives","volume":"35","author":"Ohno","year":"2010","journal-title":"J. Pestic. Sci."},{"key":"10.1016\/j.ejmech.2026.118753_bib36","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1080\/00397918908052602","article-title":"The selective methylation of 4-Ethoxycarbonyl-3-Methylpyrazolin-5-One with dimethyl sulfate","volume":"19","author":"Jur\u0161i\u0107","year":"1989","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2026.118753_bib37","series-title":"Applications of Heterocycles in the Design of Drugs and Agricultural Products","first-page":"185","article-title":"Hydroxyazoles as acid isosteres and their drug design applications\u2014Part 1: monocyclic systems","author":"Sainas","year":"2021"},{"key":"10.1016\/j.ejmech.2026.118753_bib38","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1107\/S0907444902003451","article-title":"The protein data bank","volume":"58","author":"Berman","year":"2002","journal-title":"Acta. Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2026.118753_bib39","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1021\/acs.jcim.3c00278","article-title":"MolBook UNIPI\u2500Create, manage, analyze, and share your chemical data for free","volume":"63","author":"Galati","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.118753_bib40","series-title":"MolBook Pro 2025","author":"Galati","year":"2025"},{"key":"10.1016\/j.ejmech.2026.118753_bib41","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/prot.10465","article-title":"Improved protein-ligand docking using GOLD","volume":"52","author":"Verdonk","year":"2003","journal-title":"Proteins"},{"key":"10.1016\/j.ejmech.2026.118753_bib42","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jfluchem.2007.07.011","article-title":"Synthesis and characterisation of 3- and 4-(pentafluorosulfanyl)benzoic acid derivatives","volume":"128","author":"Zarantonello","year":"2007","journal-title":"J. Fluor. Chem."},{"key":"10.1016\/j.ejmech.2026.118753_bib43","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.ejmech.2018.03.040","article-title":"Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acid","volume":"150","author":"Pippione","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118753_bib44","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1039\/C4CC09674F","article-title":"Salicylic acids as readily available starting materials for the synthesis of meta-substituted biaryls","volume":"51","author":"Luo","year":"2015","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2026.118753_bib45","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1107\/S2059798324004066","article-title":"An alternative conformation of the N-terminal loop of human dihydroorotate dehydrogenase drives binding to a potent antiproliferative agent","volume":"80","author":"Alberti","year":"2024","journal-title":"Acta Crystallogr. D"},{"key":"10.1016\/j.ejmech.2026.118753_bib46","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/1873-3468.14680","article-title":"Biochemical characterization of Mycobacterium tuberculosis dihydroorotate dehydrogenase and identification of a selective inhibitor","volume":"597","author":"Alberti","year":"2023","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"key":"10.1016\/j.ejmech.2026.118753_bib47","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta. Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2026.118753_bib48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta. Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2026.118753_bib49","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta. Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2026.118753_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26041019","article-title":"Trichilianones A-D, novel cyclopropane-type limonoids from Trichilia adolfi","volume":"26","author":"Limachi","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118753_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116193","article-title":"Structure-guided optimization of 3-hydroxybenzoisoxazole derivatives as inhibitors of Aldo-keto reductase 1C3 (AKR1C3) to target prostate cancer","volume":"268","author":"Pippione","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118753_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114366","article-title":"New aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the hydroxytriazole scaffold","volume":"237","author":"Pippione","year":"2022","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426001984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426001984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T21:14:57Z","timestamp":1784668497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426001984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":52,"alternative-id":["S0223523426001984"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118753","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-based design of new pyrazole inhibitors targeting Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118753","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118753"}}